MedTrace Logo

Effects of Creatine and Rehabilitation Programin Athletes With Patellar Tendinopathy

NCT06482619 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2024-07-01

No results posted yet for this study

Summary

The aim of this study are to analyze the effect of creatine ingestion in pain, histological properties of the tendon, body composition, strength and vertical jump performance in athletes with patellar tendinopathy that follow a physical rehabilitation program that include eccentric exercise combined with stretching and extracorporeal shock wave therapy.

Conditions

  • Creatine
  • Patellar Tendinopathy

Interventions

DIETARY_SUPPLEMENT

Creatine supplementation

The supplements were provided in capsules of 1 g of red color not transparent Guinama S.L.U, 0044634, La Pobla de Valbona, Spain) which were prepared with a Capsunorm 2000 semi-automatic manual capsule filling machine (Miranda del Ebro, Spain). Capsules contained creatine monohidrate (Creapure, Crown Sport Nutrition, Arnedo, Spain)

DIETARY_SUPPLEMENT

Placebo

The supplements were provided in capsules of 1 g of red color not transparent Guinama S.L.U, 0044634, La Pobla de Valbona, Spain) which were prepared with a Capsunorm 2000 semi-automatic manual capsule filling machine (Miranda del Ebro, Spain). Capsules contained placebo (i.e., sucrose)

Sponsors & Collaborators

  • Universidad de Córdoba

    collaborator OTHER

  • University of Bologna

    collaborator OTHER

  • Technical University of Madrid

    collaborator OTHER

  • Lavras University

    collaborator UNKNOWN

  • Universidad Pontificia Comillas

    lead OTHER

Principal Investigators

  • Angela Sánchez-Gómez, PhD · Universidad de Córdoba

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-08-30
Completion
2023-11-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06482619 on ClinicalTrials.gov